research COVID-19 and Skin (A New Chapter in Dermatology)
COVID-19 can cause skin problems directly or from using protective gear and sanitizers, and knowing this can help treat patients better.
Search
for
Sort by
Research
300-330 / 1000+ results 
research Telogen Effluvium and COVID-19: a case and a brief review of literature
COVID-19 may cause temporary hair loss due to the body's immune response.
research Impact of the COVID‐19 pandemic on inpatient dermatology: a multicentre study from Hubei, China
COVID-19 led to fewer dermatology admissions in Hubei, China, with more severe cases and increased eczema due to mask use and hand disinfectants.
research Acquired progressive kinking of the hair following COVID‐19 disease
COVID-19 can cause hair to become progressively kinked.
research Dermatological Manifestations of Patients with COVID 19: A Cross-sectional study
COVID-19 can cause skin problems.
research Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2
Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.
research ШКІРНІ ПРОЯВИ ПРИ COVID-19 ТА НА ЕТАПІ ПОСТКОВІДНОГО СИНДРОМУ
COVID-19 can cause skin issues during and after infection.
research Risks of alopecia areata in long COVID: Binational population‐based cohort studies from South Korea and Japan
COVID-19 increases the risk of hair loss, but vaccination can reduce this risk.
research Effect of COVID-19 on Hair Diseases Observed by Health Care Providers: Analysis of 513 participants
COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.
research Acute Telogen Effluvium: A Post-COVID-19 Sequela
COVID-19 infection may cause hair loss.
research A skin organoid-based infection platform identifies an inhibitor specific for HFMD
NSC167409 can effectively inhibit the virus causing hand, foot, and mouth disease.
research Gene detection in a family with monilethrix and observation of the treatment effect with 5% topical minoxidil
5% topical minoxidil improves hair density and quality in monilethrix patients.
research COVID-19 pandemic and teledermatology in low-income regions
The COVID-19 pandemic increased the use of teledermatology to treat skin conditions in low-income areas, despite challenges like poor photo quality.
research Clinical symptoms of hyperandrogenic women diagnosed with COVID‐19
Women with high androgen levels may have more severe COVID-19 symptoms.
research The relationship between coronavirus disease 2019 (COVID-19) vaccines, abnormal uterine bleeding, and hormonal disorders in women of reproductive age: one-center cross-sectional results
COVID-19 vaccines are linked to menstrual changes in many women.
research Telogen Effluvium and COVID-19
COVID-19 may cause hair loss months after infection.
research The impact of healthcare setting on post-COVID mood disorders: a single-centre perspective from Southern Italy Respiratory Intensive Care Unit
Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.
research Gain‐of‐function variants in the ODC1 gene cause a syndromic neurodevelopmental disorder associated with macrocephaly, alopecia, dysmorphic features, and neuroimaging abnormalities
ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.
research Prominent Cutaneous Manifestation of COVID-19: A Case Report
A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.
research The Multisystem Impact of Long COVID: A Comprehensive Review
Long COVID affects many body systems and needs careful management.
research Autosomal dominant monilethrix with incomplete penetrance due to a novel KRT86 mutation in a Chinese family
research Features of hemorheological disorders in patients with alopecia associated with coronavirus infection
COVID-19-related hair loss may be linked to blood flow disorders and inflammation.
research Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients
SARS-CoV-2 may worsen IPF due to shared genes and pathways, suggesting potential drug targets.
research 32731 Alopecia in COVID-19 patients: Systematic review and meta-analysis
Different types of hair loss are linked to COVID-19, with some types possibly increasing risk of getting the virus, while others may be triggered or worsened by the virus.
research Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity
COVID-19 patients may experience hair loss, but it's not linked to their age or sex.
research Prevalence and Pattern of Skin Manifestations in COVID-19 Patients; A Cross-Sectional Observational Study in Saudi Arabia
Some COVID-19 patients in Saudi Arabia had skin symptoms, with rashes being the most common.
research Werewolf, There Wolf: Variants in Hairless Associated with Hypotrichia and Roaning in the Lykoi Cat Breed
Lykoi cats' unique sparse hair is linked to specific genetic variants in the Hairless gene.
research Reporting Cases of Telogen Effluvium as a sequelae of COVID‐19 Infection
COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.
research Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.
research Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population
Mutations in the spike protein affect drug binding and effectiveness.